← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Denosumab currently has availability issues reported in 3 European registers: Austria, Italy, Sweden.
Shortage ATC — · also listed as: DENOSUMAB · data refreshed 12 September 2026
As of 12 September 2026, 3 of the 9 tracked registers list current availability issues for Denosumab, covering 7 affected product presentations. The longest-running open report was filed in Sweden on 2026-03-01 and has now been open for about 6 months. Where agencies state a cause, unexpectedly high demand lead with 5 of the 5 stated-cause reports. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 5 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Sweden reported first (2026-03-01), with Austria following roughly 4 months later — a pattern typical of supply problems cascading between national markets. Registers in Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage ZADENVI 60 mg Injektionslösung in einer Fertigspritze | 2026-07-22 | — | — | register ↗ |
| 🇮🇹 Italy | Shortage BILDYOS + 4 more productsJUBEREQ OBODENCE OSENVELT STOBOCLO | 2026-06-09 | — | Elevata richiesta Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
| 🇸🇪 Sweden | Shortage Osvyrti 60 mg Injektionsvätska, lösning i förfylld spruta | 2026-03-01 | 2026-07-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Denosumab in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | OBODENCE | Shortage | 2026-08-10 | — | Elevata richiesta |
| 🇦🇹 AT | ZADENVI 60 mg Injektionslösung in einer Fertigspritze | Shortage | 2026-07-22 | — | |
| 🇮🇹 IT | BILDYOS | Shortage | 2026-07-08 | — | Elevata richiesta |
| 🇮🇹 IT | OSENVELT | Shortage | 2026-06-29 | — | Elevata richiesta |
| 🇮🇹 IT | JUBEREQ | Shortage | 2026-06-26 | — | Elevata richiesta |
| 🇮🇹 IT | STOBOCLO | Shortage | 2026-06-09 | — | Elevata richiesta |
| 🇸🇪 SE | Osvyrti 60 mg Injektionsvätska, lösning i förfylld spruta | Shortage | 2026-03-01 | 2026-07-31 |
Yes. As of 12 September 2026, availability issues are reported in: Austria, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
6 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Denosumab: BASG (Austria), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Denosumab — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/denosumab/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Denosumab availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/denosumab/">Denosumab shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>